Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    Ixmyelocel-T
Show Display Options
Rank Status Study
1 Active, not recruiting An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)
Condition: Ischemic Dilated Cardiomyopathy (IDCM)
Interventions: Biological: ixmyelocel-T;   Other: Vehicle Control
2 Completed An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)
Condition: Critical Limb Ischemia
Interventions: Biological: Ixmyelocel-T;   Other: Placebo
3 Completed Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head
Condition: Osteonecrosis
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care Only
4 Completed Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia
Condition: Peripheral Arterial Disease
Interventions: Biological: Ixmyelocel-T;   Biological: Placebo
5 Completed Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care
6 Completed Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care
7 Completed Cell Therapy for Craniofacial Bone Defects
Conditions: Cleft Palate;   Trauma
Interventions: Biological: Ixmyelocel-T;   Procedure: Autogenous Bone Grafting
8 Completed
Has Results
Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy
Condition: Alveolar Bone Loss
Interventions: Biological: Tissue Repair Cells (TRC);   Device: Control

Indicates status has not been verified in more than two years